First Trust Advisors’s Array Biopharma Inc ARRY Stock Holding History

First Trust Advisors’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-225,331	Closed	-$10.4M	–	2564
2019 Q2	$10.4M	Buy	225,331 +4,048	+2%	+$114K	0.02%	757
2019 Q1	$5.39M	Buy	+221,283	New	+$4.61M	0.01%	976
2018 Q4	–	Sell	-134,205	Closed	-$2.04M	–	2525
2018 Q3	$2.04M	Sell	134,205 -1,262	-0.9%	-$19.3K	﹤0.01%	1658
2018 Q2	$2.27M	Buy	135,467 +45,451	+50%	+$723K	﹤0.01%	1560
2018 Q1	$1.47M	Sell	90,016 -48,389	-35%	-$775K	﹤0.01%	1633
2017 Q4	$1.77M	Buy	138,405 +2,125	+2%	+$24.2K	﹤0.01%	1594
2017 Q3	$1.68M	Sell	136,280 -87,625	-39%	-$814K	﹤0.01%	1594
2017 Q2	$1.87M	Buy	+223,905	New	+$1.83M	0.01%	1520

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

First Trust Advisors's ARRY Position: Q3 2019 in Review

First Trust Advisors sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 225,331 shares — an estimated $10.4M sold.

First Trust Advisors first reported a position in ARRY in Q2 2017 and held it in 8 quarters. The position peaked at $10.4M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

First Trust Advisors reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
First Trust Advisors sold 225,331 Array Biopharma Inc shares in Q3 2019, an estimated $10.4M.
First Trust Advisors first reported a position in Array Biopharma Inc in Q2 2017 and held it in 8 quarters.
First Trust Advisors's Array Biopharma Inc position peaked at $10.4M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on First Trust Advisors's 13F filing for Q3 2019, filed 4 Nov 2019.